Palisade Bio Inc (NASDAQ: PALI) open the trading on Thursday, with great promise as it jumped 68.57% to $2.36, before settling in for the price of $1.40 at the close. Taking a more long-term approach, PALI posted a 52-week range of $1.38-$22.35.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been -38.82% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 75.28%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 54.26%. This publicly-traded company’s shares outstanding now amounts to $1.43 million, simultaneously with a float of $1.40 million. The organization now has a market capitalization sitting at $3.37 million. At the time of writing, stock’s 50-day Moving Average stood at $2.8100, while the 200-day Moving Average is $4.3000.
Palisade Bio Inc (PALI) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Palisade Bio Inc’s current insider ownership accounts for 1.67%, in contrast to 4.36% institutional ownership. According to the most recent insider trade that took place on May 28 ’24, this organization’s Director bought 1,000 shares at the rate of 4.86, making the entire transaction reach 4,863 in total value, affecting insider ownership by 1,000. Preceding that transaction, on May 24 ’24, Company’s CEO, CFO, Director bought 1,000 for 4.81, making the whole transaction’s value amount to 4,810. This particular insider is now the holder of 8,437 in total.
Palisade Bio Inc (PALI) Earnings and Revenue Records
Palisade Bio Inc’s EPS increase for this current 12-month fiscal period is 54.26% and is forecasted to reach -3.81 in the upcoming year.
Palisade Bio Inc (NASDAQ: PALI) Trading Performance Indicators
Let’s observe the current performance indicators for Palisade Bio Inc (PALI). It’s Quick Ratio in the last reported quarter now stands at 3.28. The Stock has managed to achieve an average true range (ATR) of 0.39.
In the same vein, PALI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -15.04, a figure that is expected to reach -2.24 in the next quarter, and analysts are predicting that it will be -3.81 at the market close of one year from today.
Technical Analysis of Palisade Bio Inc (PALI)
[Palisade Bio Inc, PALI] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 19.33% While, its Average True Range was 0.4500.
Raw Stochastic average of Palisade Bio Inc (PALI) in the period of the previous 100 days is set at 29.97%, which indicates a major fall in contrast to 51.04% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 258.03% that was higher than 120.98% volatility it exhibited in the past 100-days period.
